Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunosuppressive Withdrawal in Pediatric Liver Transplant
NCT06147375Not yet recruiting
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Peptides, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus and cyclosporine in liver transplantation. Primary endpoint: Number of immune tolerance participants. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
tacrolimuscyclosporine
03
Conditions
liver transplantation
Beyond the preview
Go deeper on NCT06147375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06147375.